The Effect of SunGold Kiwifruit on Gut Health Functio

Not Applicable

Completed

• Conditions: Constipation; Irritable Bowel Syndrome; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12616000775415
• Lead Sponsor: The New Zealand Institute for Plant & Food Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-14
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Functionally Constipated Group and Irritable Bowel Sydrome with constipation group: Adult (18-65 years), BMI 18-25, Both male and female (females will be required to declare stage of menstrual cycle during different trial stages), Presence of Functional Constipation or Irritable Bowel Syndrome according to ROME III diagnostic criteria.

Exclusion Criteria

1. Alarm features associated with bowel habit (recent changes in bowel habit (<3 months), rectal bleeding, weight loss, blood in stools, bleeding haemorrhoids, family history of Gastrointestinal (GI) cancer or Irritable Bowel Disease (IBD).

2. Chronic disease (cardiovascular, cancer, renal failure, previous GI surgery (not including appendectomy or cholecystectomy), neurological conditions (e.g. stroke, spinal chord injury, multiple sclerosis)

3. Fasting blood glucose of 6.0 mmol/l or greater. Participants will be screened during recruitment.

4. Participants with diagnosed and stable conditions requiring the use of selective serotonin uptake inhibitors, triglycerides, opiates or anti-inflammatories will only be permitted into the trial on condition that the medication has been in use continually and the condition has been stable for > 3 months. Similarly those with stable and controlled diabetes for > 3 months will also be permitted to take part in the study.

5. Women who are pregnant, breastfeeding or planning a pregnancy in the 3 months post selection will be excluded.

6. Potential participants with known kiwifruit or latex allergy will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified